Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Down 64.1% in August

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) saw a large decrease in short interest in August. As of August 31st, there was short interest totaling 327,738 shares, a decrease of 64.1% from the August 15th total of 913,482 shares. Based on an average daily volume of 718,829 shares, the short-interest ratio is currently 0.5 days. Approximately 0.5% of the company’s stock are short sold.

Institutional Investors Weigh In On Bioceres Crop Solutions

An institutional investor recently raised its stake in Bioceres Crop Solutions stock. Ardsley Advisory Partners LP increased its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 691.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 475,000 shares of the company’s stock after acquiring an additional 415,000 shares during the period. Ardsley Advisory Partners LP owned approximately 0.75% of Bioceres Crop Solutions worth $622,000 at the end of the most recent reporting period. 17.68% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Monday, July 13th. Two research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus price target of $2.00.

Bioceres Crop Solutions Price Performance

BIOX opened at $0.43 on Tuesday. The company has a quick ratio of 0.70, a current ratio of 0.88 and a debt-to-equity ratio of 0.57. The company’s 50-day moving average price is $0.38 and its 200 day moving average price is $0.44. Bioceres Crop Solutions has a fifty-two week low of $0.30 and a fifty-two week high of $2.19. The firm has a market cap of $27.08 million, a price-to-earnings ratio of -0.11 and a beta of 0.44.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Monday, September 14th. The company reported ($0.50) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.44). Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.